Zepp Health (NYSE:ZEPP) CFO Cheng Deng Sells 9,836 Shares

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) CFO Cheng Deng sold 9,836 shares of Zepp Health stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $4.61, for a total value of $45,343.96. Following the completion of the transaction, the chief financial officer owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. The trade was a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Zepp Health Stock Up 4.7%

NYSE:ZEPP opened at $4.70 on Tuesday. The company has a current ratio of 0.88, a quick ratio of 0.67 and a debt-to-equity ratio of 0.21. The stock has a 50 day moving average of $9.60 and a 200-day moving average of $16.96. The firm has a market capitalization of $68.98 million, a PE ratio of -1.86 and a beta of 1.78. Zepp Health Corporation Sponsored ADR has a 52 week low of $2.50 and a 52 week high of $61.85.

Institutional Investors Weigh In On Zepp Health

Several institutional investors have recently bought and sold shares of ZEPP. Public Employees Retirement System of Ohio acquired a new position in Zepp Health during the 3rd quarter valued at about $43,000. Oasis Management Co Ltd. acquired a new stake in shares of Zepp Health in the 3rd quarter worth approximately $276,000. Osaic Holdings Inc. lifted its stake in shares of Zepp Health by 239.5% in the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock worth $223,000 after acquiring an additional 5,845 shares during the period. Dimensional Fund Advisors LP bought a new position in shares of Zepp Health in the fourth quarter valued at approximately $241,000. Finally, Capstone Capital Management Ltd bought a new position in shares of Zepp Health in the fourth quarter valued at approximately $298,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ZEPP. Wall Street Zen lowered Zepp Health from a “hold” rating to a “sell” rating in a research report on Saturday. Fundamental Research set a $56.28 price target on shares of Zepp Health and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Zepp Health presently has an average rating of “Hold” and a consensus target price of $56.28.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.